USFDA approved the pharmaceutical company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg.
The anxiety-reducing drug, Clonazepam, has been recalled after a potentially "life-threatening" label mix-up, the FDA said in the recall.
The Loratadine Tablets are used in the treatment of symptoms like itching, runny nose, watery eyes, and sneezing caused by ‘hay fever’ and other allergies.